3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
318
Colonic Neoplasms
90
Rectal Neoplasms
82
Neoplasm Metastasis
42
Pancreatic Neoplasms
40
Carcinoma, Non-Small-Cell Lung
35
Esophageal Neoplasms
25
Neoplasms
21
Stomach Neoplasms
20
Esophageal Squamous Cell Carcinoma
14
Adenocarcinoma Of Esophagus
12
Squamous Cell Carcinoma of Head and Neck
11
Lung Neoplasms
11
Head and Neck Neoplasms
11
Colorectal Cancer Metastatic
11
Breast Neoplasms
9
Gastrointestinal Neoplasms
7
Ovarian Neoplasms
6
Anus Neoplasms
6
Hereditary Sensory and Autonomic Neuropathies
5
Endometrial Neoplasms
5
Cholangiocarcinoma
5
Carcinoma, Renal Cell
5
Carcinoma, Hepatocellular
5
Triple Negative Breast Neoplasms
4
Salivary Gland Neoplasms
4
Recurrence
4
Digestive System Neoplasms
4
Advanced Colorectal Cancer
4
Tongue Neoplasms
3
Interventions
pembrolizumab
1
osimertinib
1
nazartinib
1
cobimetinib
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Noonan Syndrome
×
Cetuximab
×
Gastrointestinal
×
Clear all
NCT04670679
2026-03-25
FLAGSHP-1
Erasca, Inc.
Phase 1
Active not recruiting
90 enrolled